CATALIO CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GUTS | 5.49M | $12.08M |
 | TARA | 1.45M | $7.71M |
 | HYPR | 1.32M | $1.29M |
 | ELDN | 1.26M | $1.90M |
 | SNDX | 1.20M | $25.14M |
 | ADPT | 821K | $13.34M |
 | OCUL | 715K | $8.67M |
 | PHAT | 699K | $11.60M |
 | DNTH | 654K | $26.93M |
 | BMY | 648K | $34.95M |
 | ADMA | 564K | $10.30M |
 | MGX | 529K | $856.97K |
 | DYN | 520K | $10.17M |
 | BBOT | 411K | $31.41M |
 | BSX | 360K | $34.37M |
 | SLNO | 360K | $16.68M |
 | MLYS | 332K | $12.04M |
 | SEPN | 294K | $8.21M |
 | GILD | 289K | $35.51M |
 | QURE | 288K | $6.90M |
Fractyl Health, Inc. Common Stock
GUTS
Shares Held
5.49M
Value
$12.08M
Protara Therapeutics, Inc.
TARA
Shares Held
1.45M
Value
$7.71M
Hyperfine, Inc.
HYPR
Shares Held
1.32M
Value
$1.29M
Eledon Pharmaceuticals, Inc.
ELDN
Shares Held
1.26M
Value
$1.90M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.20M
Value
$25.14M
Adaptive Biotechnologies Corporation
ADPT
Shares Held
821K
Value
$13.34M
Ocular Therapeutix, Inc.
OCUL
Shares Held
715K
Value
$8.67M
Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
699K
Value
$11.60M
Dianthus Therapeutics, Inc.
DNTH
Shares Held
654K
Value
$26.93M
Bristol-Myers Squibb Company
BMY
Shares Held
648K
Value
$34.95M
ADMA Biologics, Inc.
ADMA
Shares Held
564K
Value
$10.30M
Metagenomi, Inc. Common Stock
MGX
Shares Held
529K
Value
$856.97K
Dyne Therapeutics, Inc.
DYN
Shares Held
520K
Value
$10.17M
BridgeBio Oncology Therapeutics Inc.
BBOT
Shares Held
411K
Value
$31.41M
Boston Scientific Corporation
BSX
Shares Held
360K
Value
$34.37M
Soleno Therapeutics, Inc.
SLNO
Shares Held
360K
Value
$16.68M
Mineralys Therapeutics, Inc.
MLYS
Shares Held
332K
Value
$12.04M
Septerna, Inc.
SEPN
Shares Held
294K
Value
$8.21M
Gilead Sciences, Inc.
GILD
Shares Held
289K
Value
$35.51M
uniQure N.V.
QURE
Shares Held
288K
Value
$6.90M